5-HYDROXYMETHYLOXAZOLIDIN-2-ONDERIVATE

Patent europeic · EP2086968 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2086968
Numer da la dumonda
EP07827038
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
09-11-2007
Publitgà
12-08-2009
Concedì
08-02-2012
Stritgà
25-06-2025
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 413/14 (2006.01)
C07D 471/04 (2006.01)
A61K 31/4375 (2006.01)
A61K 31/4709 (2006.01)
A61P 31/00 (2006.01)
Prioritad
WO PCT/IB2006/054189 10.11.2006
Dumonda PCT
PCT/IB2007/054557 09.11.2007
Publicaziun PCT
WO2008/056335 15.05.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-06-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.06.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.06.2025

  2. 26-01-2024

    Midada

    Published in Swissreg on 26.01.2024

  3. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  4. 08-02-2012

    Concedì

    Published in Swissreg on 08.02.2012

Partidas

Possessur

Actelion Pharmaceuticals Ltd

Actelion Pharmaceuticals Ltd.

Gewerbestrasse 16, 4123 Allschwil

Inventur

HUBSCHWERLEN, Christian

68480 Durmenach, FR

PANCHAUD, Philippe

4123 Allschwil

SPECKLIN, Jean-Luc

68680 Kembs, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.